相关实验视频
Updated: Jan 7, 2026

04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
1.2K
抑郁症和双相情感障碍的混合特征:一个更新的系统性审查
Veronica Grasso1, Carolina Hernandorena2, Micaela Dines3
1Centro Integrador de psicoterapias Conductuales Contextuales (Fundación CIPCO), Córdoba, Argentina.
Journal of affective disorders
|December 25, 2025
概括
混合特征在严重抑郁症 (MDD) 和双相情感障碍 (BD) 中很常见,在BD中发生的频率几乎是BD的两倍. 患病率根据使用的诊断标准有很大差异.
科学领域:
- 精神病学和行为科学
- 情绪障碍 研究 研究 情绪障碍
- 精神疾病的流行病学精神疾病的流行病学
背景情况:
- 情绪障碍的混合特征得到了认可,但缺乏一致的患病率估计.
- 之前的系统性审查强调需要更新主要抑郁症 (MDD) 和双相情感障碍 (BD) 的流行数据.
研究的目的:
- 为MDD和BD中混合特征提供最新的流行率估计.
- 根据不同的诊断标准 (DSM-5与≥3个相反极性的特征) 进行比较.
主要方法:
- 在5个数据库中进行系统的文献搜索,寻找患有MDD或BD的成年人的研究.
- 包括使用DSM-5标准评估混合特征或识别≥3个相反极性的特征的研究.
- 独立的数据提取和聚合的流行率计算与置信区间.
主要成果:
- 分析了来自世界5个地区的26项研究.
- 在18.1%的MDD发作和32.8%-34.8%的BD发作 (抑郁和[低]躁狂) 中发现了混合特征.
- 与MDD相比,BD的患病率几乎是BD的两倍,并且根据诊断标准有很大的差异.
结论:
- 在情绪障碍,特别是双相情绪障碍中,混合特征非常普遍.
- 目前的患病率估计受到使用的诊断标准的严重影响.
- 诊断定义的协调对于理解预后和治疗影响至关重要.
相关概念视频
Bipolar Disorder
586
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
586
Depressive Disorders: Etiology
408
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
408
Depressive Disorders: MDD and Dysthymia
564
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
564
Depression: Overview
741
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
741
Mania and Antimanic Drugs: Overview
526
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
526
Antidepressant Drugs: MAOIs and Other Agents
765
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
765

